Prof. Roosmarijn Vandenbroucke
Prof. Roosmarijn Vandenbroucke VIB UGent-Belgium

Project description

Given the strong scientific preclinical and clinical data indicating the potential of microbiota-altering therapies for PD are promising, and the anecdotal (case study) evidence that FMT works for these patients, there is an urgent need to reliably test this potential therapy in a randomized clinical trial.

Our study will be the first worldwide to investigate the potential therapeutic effect of FMT on symptoms and disease progression in patients with PD in a double-blind, placebo-controlled randomized clinical trial (source:

Prof. Debby Laukens receiving Pr Vandenbroucke award
Award winning ceremony

Related projects

Dr. Sarah Ahannach
belgium flag
2024 Belgium winnerDr. Sarah Ahannach

Towards a better understanding of a Gut-Vagina Axis by investigating the effects of Ramadan fasting on Gut and Vaginal Microbial Communities

Charysse Vandendriessche
belgium flag
2023 Belgium winnerDr. Charysse Vandendriessche

Bacterial extracellular vesicles as biomarker for Parkinson's disease

belgium flag
2022 Belgium winnerDr. Sophie Leclercq

Influence of gut microbiota composition and function on acute and persistent post-surgical pain

Prof. Laure ELENS
belgium flag
2020 Belgium winnerProf. Laure Elens

Study of the gut human microbiome and its relationship with immunosuppressive pharmacotherapy in stable renal transplant patients

Dr. Lucas Wauters
belgium flag
2018 Belgium winnerDr. Lucas Wauters

The duodenal microbiome and effect of proton pump inhibitors in healthy volunteers and functional dyspepsia patients